- Acquista crypto
- Mercato
- Futures
- Spot
- Copy trading
WE-Launch
US Biopharmaceutical Company Liminatus Pharma Plans to Raise $500 Million to Invest in BNB
BlockBeats News, July 28th, According to a report by businessinsider, Clinical-stage biopharmaceutical company Liminatus Pharma, Inc. (NASDAQ: LIMN) today announced plans to strategically expand into the cryptocurrency and blockchain space.
The company plans to establish a subsidiary named "American BNB Strategy" to lead its digital asset investment and management plan. Through this platform, Liminatus plans to gradually raise and deploy up to $500 million in funds, with the goal of strategically long-term investing in BNB.
Liminatus emphasized that while the company remains fully committed to its core business - advancing cancer treatments and pancreatic cancer diagnostic technologies, expanding into the digital asset space is seen as a necessary step to support long-term growth and enhance shareholder value.
Liminatus is a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer patients. The company is advancing a series of novel therapies targeting cancer antigens and tumor-specific immune responses.
Potrebbe interessarti anche
Chi ha guadagnato
Ultime notizie crypto
Trump dice che il presidente della Fed dovrebbe tagliare i tassi di interesse, ribadisce le critiche a Powell
Nelle ultime 24 ore, l'intera rete ha liquidato 376 milioni di dollari, con la maggior parte proveniente dalla posizione short più grande
La probabilità di un taglio dei tassi di interesse di 25 punti base da parte della Federal Reserve a dicembre è attualmente all'87,2%.
Trump: Annuncerà la nuova presidenza della Fed all'inizio del prossimo anno
Sito internazionale di Coinbase per lanciare il trading di contratti perpetui DASH
Assistenza clienti：@weikecs
Cooperazione aziendale：@weikecs
Trading quantitativo e MM：[email protected]
Servizi VIP：[email protected]
App